ロード中...
Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
In a randomised, placebo controlled, double blind study inosine pranobex was assessed as a possible second line drug in rheumatoid arthritis. Twenty four patients received inosine pranobex (3 g/day) and 26 patients received placebo for up to 24 weeks. Morning stiffness, articular index, grip strengt...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1990
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1004071/ https://ncbi.nlm.nih.gov/pubmed/1693065 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|